Alfacell

From WikiCover

Jump to: navigation, search

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, Onconase, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of Onconase in non-small cell lung cancer (NSCLC) and other solid tumors.

Website: http://www.alfacell.com/

Retrieved from "http://www.wikicover.com/Alfacell"